Workineh Shibeshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Workineh Shibeshi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alem Gebremariam
International Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France
1 shared publication - Degena Bahrey
Department of Adult Health Nursing, School of Nursing, Aksum University, Aksum, Ethiopia
1 shared publication - Gebre Teklemariam Demoz
School of Pharmacy, Aksum University, Aksum P.O. Box 1010, Ethiopia
1 shared publication - Gebremariam Woldu
Department of Pharmacy College of Health Sciences Aksum University, Aksum, Ethiopia
1 shared publication - Gebremicheal Gebreslassie Kasahun
Department of Pharmacy, College of Health Sciences, Aksum University, Aksum, Tigray, Ethiopia
1 shared publication - Helen Yifter
College of Medicine and Health Sciences, University of Rwanda , Kigali , Rwanda
1 shared publication
Latest Publications
- Open Access
- 4 April 2019
- Published by Springer Nature in BMC Research Notes
- Vol. 12 (1) , 207
Predictors of poor glycemic control among patients with type 2 diabetes on follow-up care at a tertiary healthcare setting in Ethiopia
Contemporary clinical guidelines endorsed that glycemic control is the ultimate goal in the management patients with diabetes. The aim of this study was to assess the prevalence of glycemic control and to identify predictors of poor glycemic control in patients with type 2 diabetes (T2D). A cross-sectional study was conducted among systematically selected 357 diabetic patients. Data were collected through direct patients’ interviews and medical chart review. Binary logistic regression analyses were performed and analyzed using SPSS version 22.0. Participants’ mean age was (± SD) 56.1 ± 11.6 years. Nearly four in five (77.9%) of the participants had comorbidities, mainly of hypertension, and 60.2% had diabetic complications, mainly diabetes neuropathy. Poor glycemic control was found in 68.3% of the participants with a mean (± SD) FBG of 174.1 ± 48.9 mg/dL. Being female gender, having greater body mass index and low medication adherence was significantly associated with poor glycemic control. In conclusion, the overall aspects of glycemic control level of patients were far from the standards. Being female, greater body mass index and poor medication adherence were predictors of poor glycemic control. In response to this finding, an aggressive intervention that targets in improving the glycemic control is required.
- 4 April 2019
- Published by Springer Nature in BMC Research Notes
- Vol. 12 (1) , 207
Open AccessPredictors of poor glycemic control among patients with type 2 diabetes on follow-up care at a tertiary healthcare setting in Ethiopia
Contemporary clinical guidelines endorsed that glycemic control is the ultimate goal in the management patients with diabetes. The aim of this study was to assess the prevalence of glycemic control and to identify predictors of poor glycemic control in patients with type 2 diabetes (T2D). A cross-sectional study was conducted among systematically selected 357 diabetic patients. Data were collected through direct patients’ interviews and medical chart review. Binary logistic regression analyses were performed and analyzed using SPSS version 22.0. Participants’ mean age was (± SD) 56.1 ± 11.6 years. Nearly four in five (77.9%) of the participants had comorbidities, mainly of hypertension, and 60.2% had diabetic complications, mainly diabetes neuropathy. Poor glycemic control was found in 68.3% of the participants with a mean (± SD) FBG of 174.1 ± 48.9 mg/dL. Being female gender, having greater body mass index and low medication adherence was significantly associated with poor glycemic control. In conclusion, the overall aspects of glycemic control level of patients were far from the standards. Being female, greater body mass index and poor medication adherence were predictors of poor glycemic control. In response to this finding, an aggressive intervention that targets in improving the glycemic control is required.